This complete guide will teach you everything you need to know about eating well on GLP-1 medicationsfrom protein targets to side effect management to meal planning strategies that actually work in real life New to GLP-1s
Currently available treatments using behavioral and psychosocial interventions lead to modest improvement in outcomes
Glucagon-like peptide-1 receptor agonists and risk of suicidality: A multinational cohort study
Things like nausea, vomiting, diarrhea, and constipation are the most common
Individuals with the following conditions may need special consideration or monitoring when using GLP-1 analogues: Individualized Medical Advice: As with any medical treatment, it's essential to work closely with your healthcare provider to determine the suitability of GLP-1 analogues for your specific health needs
Nausea occurred in 16-46% of patients depending on dose, diarrhea in 16-26%, and vomiting in 8-22%